Similar Overall survival using sibling, unrelated donor, and cord blood grafts after reduced-intensity conditioning for older patients with acute myelogenous leukemia

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 9, 2013, Pages 1355-1360

  Peffault de Latour, Régis ^a,b   Brunstein, Claudio G ^c   Porcher, Raphael ^b   Chevallier, Patrice ^d   Robin, Marie ^a   Warlick, Erica ^c   Xhaard, Alienor ^a   Ustun, Celalettin ^c   Larghero, Jérôme ^d   Dhedin, Nathalie ^a,b   Mohty, Mohamad ^e,f   Socié, Gerard ^a   Weisdorf, Daniel ^c  

^a Service d'Hématologie Greffe HÔpital Saint Louis   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Unite de Therapie Cellulaire   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f Service d'Hématologie clinique HÔpital Saint Antoine   (France)

Author keywords

Acute myeloid leukemia; Cord blood; Older patients; Reduced intensity conditioning regimen; Unrelated donor

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; FOSCARNET; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOGENETICS; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OVERALL SURVIVAL; PNEUMOCYSTIS PNEUMONIA; REDUCED INTENSITY CONDITIONING; SIBLING; WHOLE BODY RADIATION; COHORT ANALYSIS; COMPARATIVE STUDY; DONOR; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; SURVIVAL; UNRELATED DONORS;

AGED; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SIBLINGS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

EID: 84882762856     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.06.006     Document Type: Article

References (28)

1. Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. JClin Oncol 2007, 25:1908-1915.
2. Itzykson R., Gardin C., Pautas C., et al. Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria. Haematologica 2011, 96:837-844.
3. Kurosawa S., Yamaguchi T., Uchida N., et al. Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission. Biol Blood Marrow Transplant 2011, 17:401-411.
4. Farag S.S., Maharry K., Zhang M.J., et al. Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant 2011, 17:1796-4803.
5. Estey E., de Lima M., Tibes R., et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Blood 2007, 109:1395-1400.
6. McClune B.L., Weisdorf D.J., Pedersen T.L., et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol 2010, 28:1878-1887.
7. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. NEngl J Med 2004, 351:2265-2275.
8. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. NEngl J Med 2004, 351:2276-2285.
9. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
10. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
11. Majhail N.S., Brunstein C.G., Tomblyn M., et al. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Biol Blood Marrow Transplant 2008, 14:282-289.
12. Brunstein C.G., Laughlin M.J. Extending cord blood transplant to adults: dealing with problems and results overall. Semin Hematol 2010, 47:86-96.
13. Majhail N.S., Brunstein C.G., Shanley R., et al. Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors. Bone Marrow Transplant 2012, 47:494-498.
14. Grimwade D., Walker H., Harrison G., et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001, 98:1312-1320.
15. Petersdorf E.W., Anasetti C., Martin P.J., et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004, 104:2976-2980.
16. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
17. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
18. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991, 28:250-259.
19. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
20. Kalbfleich J., Prentice R.L. The statistical analysis of failure time data 1980, John Wiley & Sons, New York.
21. Prentice R.L., Kalbfleisch J.D., Peterson A.V., et al. The analysis of failure times in the presence of competing risks. Biometrics 1978, 34:541-554.
22. Grambsch P., Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994, 81:515-556.
23. Ripatti S., Palmgren J. Estimation of multivariate frailty models using penalized partial likelihood. Biometrics 2000, 56:1016-1022.
24. Eapen M., Rocha V., Sanz G., et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
25. Alyea E.P., Kim H.T., Ho V., et al. Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 2006, 12:1047-1055.
26. de Lima M., Anagnostopoulos A., Munsell M., et al. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood 2004, 104:865-872.
27. Shimoni A., Hardan I., Shem-Tov N., et al. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity. Leukemia 2006, 20:322-328.
28. Gyurkocza B., Storb R., Storer B.E., et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. JClin Oncol 2010, 28:2859-2867.